WESTFIELD CAPITAL MANAGEMENT CO LP - 31 Dec 2024 SCHEDULE 13G/A Report for Ascendis Pharma A/S Common Stock (ASND)

Filing Manager: WESTFIELD CAPITAL MANAGEMENT CO LP
Reporting Manager: Westfield Capital Management Company, L.P.
Security: Ascendis Pharma A/S Common Stock
Symbol: ASND
Shares outstanding: 60,220,468 shares
Disclosed Ownership: 5,528,239 shares
Ownership: 9.2%
Form type: SCHEDULE 13G/A
Filing time: 11 Feb 2025, 09:15:25 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Westfield Capital Management Company, L.P.	9.2%	5,528,239	3,870,550	0	Brandi McMahon	Vice President, Deputy Chief Compliance Officer